Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spectral Analytics Precision Tele-Monitoring is a private U.S. healthcare technology and clinical research solutions company focused on digital infrastructure for patient monitoring and clinical trials. The company markets an integrated platform that includes electronic data capture, electronic patient-reported outcomes, electronic source documentation, tele-monitoring, and AI-enabled patient recruitment tools such as CannaBot and DrBot. Its positioning appears to be closer to a health-tech and clinical trial enablement vendor than a traditional therapeutics developer, although historical references also describe Spectral Analytics, Inc. as involved in clinical research and drug development. Publicly available information indicates leadership by founder and CEO Christina DiArcangelo and operations tied to Pennsylvania, with some historical references to New York. Overall, the business appears to serve pharmaceutical and healthcare stakeholders through patient-centric data collection, remote monitoring, and study-support technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spectral Analytics.